Post-Op Recovery - Orexin
Research payments
$1,510,297
Through program year 2025, $1,510,297 in research payments was reported against Post-Op Recovery - Orexin, across 396 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..
- Paid by
- Takeda Pharmaceuticals U.S.A., Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $252,998 | 65 |
| 2024 | Research | $981,891 | 277 |
| 2023 | Research | $275,408 | 54 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Steven Minear Weston, FL Named on 23 payments
- Sabry Ayad Cleveland, OH Named on 18 payments
- Syed Azim Stony Brook, NY Named on 18 payments
- Vijay Tarnal Ann Arbor, MI Named on 18 payments
- Robert Bennett Tampa, FL Named on 17 payments
- Michael Essandoh Columbus, OH Named on 17 payments
- Yiliam Rodriguez Miami, FL Named on 17 payments
- Ricardo Verdiner Scottsdale, AZ Named on 15 payments
- Linda Aglio Boston, MA Named on 13 payments
- Christine Boxhorn Milwaukee, WI Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.